Patent · US Active

Antibodies that bind B7L-1

US7939640B2 · kind B2 · utility

3Cited by
2References
2Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 26, 2010
Grant dateMay 10, 2011
Priority date
Expiry dateFeb 26, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2799/027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to B7L-1 as a purified and isolated protein, the DNA encoding the B7L-1, host cells transfected with cDNAs encoding B7L-1 and processes for preparing B7L-1 polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.